1887

Abstract

SUMMARY

Murine cytomegalovirus (MCMV)-immune lymph node (LN) cells were generated following 4 days culture of draining popliteal LN cells removed after bilateral hind footpad inoculation of mice with 4 × 10 p.f.u. MCMV. This cell population expressed both cytotoxic activity against MCMV-infected mouse embryo fibroblasts (MEF) and the capacity to release lymphokine upon stimulation with MCMV-infected MEF. Cytotoxicity and lymphokine release were Class I, H-2-restricted, virus-specific and dependent upon Thy1.2, Lyt2 cells. Mixing of 5 × 10 MCMV-immune T cells with an excess of syngeneic MCMV-infected MEF stimulators produced detectable levels of the lymphokine interleukin-3 by 1 h, with a maximum rate of its release between 1 and 6 h and plateau levels by 14 h. The capacity to stimulate virus-specific MCMV-immune T cells was acquired by MEF at 1 h after MCMV infection with maximum stimulator ability attained by 8 h. In the presence of a fixed number of MCMV-immune T cells, and titration to excess of syngeneic 3 h or 18 h MCMV-infected MEF, lower interleukin-3 plateau levels were obtained with 3 h than with 18 h MCMV-infected stimulators. This suggested that fewer T cells responded to 3 h than to 18 h MCMV-infected MEF.

Keyword(s): cytotoxicity , lymphokine and MCMV
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-66-12-2551
1985-12-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/66/12/JV0660122551.html?itemId=/content/journal/jgv/10.1099/0022-1317-66-12-2551&mimeType=html&fmt=ahah

References

  1. Ada G.L., Jackson D.C., Blanden R.V., Tha Hla R., Bowern N.A. 1976; Changes in the surface of virus-infected cells recognised by cytotoxic T cells. Scandinavian Journal of Immunology 5:23–30
    [Google Scholar]
  2. Bazill G. W., Haynes M., Garland J., Dexter T. M. 1983; Characterization and partial purification of a haemopoietic cell growth factor in WEHI-3 cell conditioned medium. Biochemical Journal 210:747–759
    [Google Scholar]
  3. Burgess A. W., Metcalf D., Russell S. H. M., Nicola N. A. 1980; Granulocyte-macrophage, megakaryocyte-, eosinophil-and erythroid-colony-stimulating factors produced by mouse spleen cells. Biochemical Journal 185:301–314
    [Google Scholar]
  4. Cantor H., Boyse E. A. 1975; Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. Journal of Experimental Medicine 141:1390–1399
    [Google Scholar]
  5. Clark-Lewis I., Schrader J. W. 1981; P cell-stimulating factor: biochemical characterisation of a new T cell-derived factor. Journal of Immunology 127:1941–1947
    [Google Scholar]
  6. Dexter T. M., Garland J. M., Scott D., Scolnick E., Metcalf D. 1980; Growth of factor-dependent haemopoietic precursor cell lines. Journal of Experimental Medicine 152:1036
    [Google Scholar]
  7. Dy M., Lebel B., Kamoun P., Hamburger J. 1981; Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis. Journal of Experimental Medicine 153:293–309
    [Google Scholar]
  8. Fung M. C., Hapel A. J., Ymer S., Cohen D. R., Johnson R. M., Campbell H. D., Young I. G. 1984; Molecular cloning of cDNA for murine interleukin-3. Nature, London 307:233–237
    [Google Scholar]
  9. Ho M. 1980; Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infection and Immunity 27:767–776
    [Google Scholar]
  10. Ihle J. N., Lee J. C., Rebar L. 1981a; T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20-α-hydroxysteroid dehydrogenase in splenic lymphocytes. Journal of Immunology 127:2565–2570
    [Google Scholar]
  11. Ihle J. N., Pepersack L., Rebar L. 1981b; Regulation of T cell differentiation: in vitro induction of 20-a-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. Journal of Immunology 126:2184–2189
    [Google Scholar]
  12. Ihle J. N., Keller J., Oroszlan S., Henderson L. E., Copeland J. D., Fitch F., Prystowsky M. B., Goldwasser E., Schrader J. W., Palaszynski E., Dy M., Lebel B. 1983; Biological properties of homogeneous interleukin-3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P-cell stimulating factor activity, colony stimulating factor activity, and histamine-producing cell stimulating factor activity. Journal of Immunology 131:282–287
    [Google Scholar]
  13. Iscove N. N., Roitsch C. A., Williams N., Guilbert L. J. 1982; Molecules stimulating early red cell, granulocyte, macrophage and megakaryocyte precursors in culture: similarity in size, hydrophobicity and charge. Journal of Cellular Physiology supplement 1:65–78
    [Google Scholar]
  14. Johnson G. R., Metcalf D. 1977; Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin. Proceedings of the National Academy of Sciences, U. S. A 74:3879–3882
    [Google Scholar]
  15. Lafferty K. J., Andrus L., Prowse S. J. 1980a; Role of lymphokine and antigen in the control of specific T cell responses. Immunological Reviews 51:279–314
    [Google Scholar]
  16. Lafferty K. J., Prowse S. J., Al-Adra A., Waren H. S., Vasalli J., Reich E. 1980b; An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. Australian Journal of Experimental Biology and Medical Science 58:533–544
    [Google Scholar]
  17. Lee J. C., Hapel A. J., Ihle J. N. 1982; Constitutive production of a unique lymphokine (IL3) by the WEHI-3 cell line. Journal of Immunology 128:2393–2398
    [Google Scholar]
  18. Morris A. G., Lin Y.-L., Askonas B. A. 1982; Immune interferon release when cloned cytotoxic T-cell meets its correct influenza-infected target cells. Nature, London 295:150–152
    [Google Scholar]
  19. Pfizenmaier K., Jung H., Starzinski-Powitz A., Rollinghoff M., Wagner H. 1977; The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. Journal of Immunology 119:939–944
    [Google Scholar]
  20. Sarmiento M., Glasebrook A. L., Fitch F. W. 1980; IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell mediated cytolysis in the absence of complement. Journal of Immunology 125:2665–2672
    [Google Scholar]
  21. Sinickas V. G., Ashman R. B., Blanden R. V. 1985a; The cytotoxic response to murine cytomegalovirus. I. Parameters in vivo. Journal of General Virology 66:747–755
    [Google Scholar]
  22. Sinickas V. G., Ashman R. B., Blanden R. V. 1985b; The cytotoxic response to murine cytomegalovirus. II. In vitro requirements for generation of cytotoxic T cells. Journal of General Virology 66:757–765
    [Google Scholar]
  23. Vignaux F., Gresser I. 1978; Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts. Proceedings of the Society for Experimental Biology and Medicine 157:456–460
    [Google Scholar]
  24. Yap K. L., Ada G. L. 1977; Cytotoxic T cells specific for influenza virus-infected target cells. Immunology 32:151–159
    [Google Scholar]
  25. Yung Y.-P., Eger R., Tertian G., Moore M. A. S. 1981; Long term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. Journal of Immunology 127:794–799
    [Google Scholar]
  26. Zlotnik A., Roberts W. K., Vasil A., Blumenthal E., Larosa F., Leibson H. J., Endres R. O., Graham S. D., White J., Hill J., Henson P., Klein J. R., Bevan M. J., Marrack P., Kappler J. W. 1983; Co-ordinate production by a T cell hybridoma of gamma-interferon and three other lymphokine activities: multiple activities of a single lymphokine. Journal of Immunology 131:794–800
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-66-12-2551
Loading
/content/journal/jgv/10.1099/0022-1317-66-12-2551
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error